HHS Drug Cost Forum: Merck, Novartis To Represent Industry View
This article was originally published in The Pink Sheet Daily
Executive Summary
The two big pharmas are the only representatives of branded drug manufacturers scheduled to participate in the meeting. GPhA’s Chip Davis is on the agenda to represent the generic drug industry's point of view.